We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > antibody cocktail

News List

Research body recommends COVID-19 drug firstwordpharma
August 02, 2021
Australia's National COVID-19 Clinical Evidence Taskforce issued a new recommendation conditionally backing use of Regeneron's COVID-19 antibody cocktail REGEN-COV (casirivimab/imdevimab), as reported Sunday in This is Money.
Regeneron Starts Phase 3 Trial for Coronavirus Antibody Cocktail contractpharma
July 07, 2020
Anti-viral antibody cocktail REGN-COV2 is also in Phase 2/3 treatment trials following positive Phase 1 safety review.
Regeneron Begins Trials of Anti-Viral Antibody Cocktail for COVID-19 americanpharmaceuticalreview
June 22, 2020
Regeneron Pharmaceuticals announced initiation of the first clinical trial of REGN-COV2, its investigational dual antibody cocktail for the prevention and treatment of COVID-19.